The U.S. Food and Drug Administration has approved a UK company's cannabis-based medicine for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet...

Australia's Creso Pharma Limited (ASX:CPH) says it has reached final stage of development for a new hemp-based lozenge product containing cannabidiolic acid (CBDA).The cannabinoids...

Jazz Pharmaceuticals subsidiary GW Pharmaceuticals has announced it has received approval in the UK for the use of Epidyolex to manage seizures associated with...

South Dakota has (finally) joined the growing list of US states with a medical cannabis program - sort of.South Dakota Initiated Measure 26 (IM-26),...